| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis KM Sjoquist, BH Burmeister, BM Smithers, JR Zalcberg, RJ Simes, ... The lancet oncology 12 (7), 681-692, 2011 | 1901 | 2011 |
| Final trial report of sentinel-node biopsy versus nodal observation in melanoma DL Morton, JF Thompson, AJ Cochran, N Mozzillo, OE Nieweg, DF Roses, ... New England Journal of Medicine 370 (7), 599-609, 2014 | 1611 | 2014 |
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis V Gebski, B Burmeister, BM Smithers, K Foo, J Zalcberg, J Simes The lancet oncology 8 (3), 226-234, 2007 | 1495 | 2007 |
| Completion dissection or observation for sentinel-node metastasis in melanoma MB Faries, JF Thompson, AJ Cochran, RH Andtbacka, N Mozzillo, ... New England Journal of Medicine 376 (23), 2211-2222, 2017 | 1376 | 2017 |
| Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ... The lancet oncology 6 (9), 659-668, 2005 | 1110 | 2005 |
| International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG) DE Low, D Alderson, I Cecconello, AC Chang, GE Darling, XB D'Journo, ... Annals of surgery 262 (2), 286-294, 2015 | 988 | 2015 |
| Benchmarking complications associated with esophagectomy DE Low, MK Kuppusamy, D Alderson, I Cecconello, AC Chang, G Darling, ... Annals of surgery 269 (2), 291-298, 2019 | 667 | 2019 |
| Comparison of the outcomes between open and minimally invasive esophagectomy BM Smithers, DC Gotley, I Martin, JM Thomas Annals of surgery 245 (2), 232-240, 2007 | 554 | 2007 |
| Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations DE Low, W Allum, G De Manzoni, L Ferri, A Immanuel, MK Kuppusamy, ... World journal of surgery 43, 299-330, 2019 | 520 | 2019 |
| Worldwide esophageal cancer collaboration TW Rice, VW Rusch, C Apperson-Hansen, MS Allen, LQ Chen, JG Hunter, ... Diseases of the Esophagus 22 (1), 1-8, 2009 | 509* | 2009 |
| High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’screening of hypertensive patients M Stowasser, RD Gordon, TG Gunasekera, DC Cowley, G Ward, ... Journal of hypertension 21 (11), 2149-2157, 2003 | 385 | 2003 |
| Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial BH Burmeister, JM Thomas, EA Burmeister, ET Walpole, JA Harvey, ... European journal of cancer 47 (3), 354-360, 2011 | 369 | 2011 |
| Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus DC Whiteman, S Sadeghi, N Pandeya, BM Smithers, DC Gotley, CJ Bain, ... Gut 57 (2), 173-180, 2008 | 366 | 2008 |
| Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial BH Burmeister, MA Henderson, J Ainslie, R Fisher, J Di Iulio, BM Smithers, ... The lancet oncology 13 (6), 589-597, 2012 | 361 | 2012 |
| Laparoscopic versus open appendectomy: prospective randomized trial JB Hansen, BM Smithers, D Schache, DR Wall, BJ Miller, BL MenZies World journal of surgery 20, 17-21, 1996 | 355 | 1996 |
| Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 M Coory, P Baade, J Aitken, M Smithers, GRC McLeod, I Ring Cancer Causes & Control 17, 21-27, 2006 | 305 | 2006 |
| Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis K Nones, N Waddell, N Wayte, AM Patch, P Bailey, F Newell, O Holmes, ... Nature communications 5 (1), 5224, 2014 | 296 | 2014 |
| TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an … T Leong, BM Smithers, K Haustermans, M Michael, V Gebski, D Miller, ... Annals of surgical oncology 24, 2252-2258, 2017 | 253 | 2017 |
| Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02 … MA Henderson, BH Burmeister, J Ainslie, R Fisher, J Di Iulio, BM Smithers, ... The Lancet Oncology 16 (9), 1049-1060, 2015 | 237 | 2015 |
| Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer U Zingg, BM Smithers, DC Gotley, G Smith, A Aly, A Clough, AJ Esterman, ... Annals of surgical oncology 18, 1460-1468, 2011 | 229 | 2011 |
